As the AHA and its members continue to address maternal mortality, the association today voiced support for the Joint Commission’s recently proposed standards for perinatal safety. “Specifically, we support the Joint Commission’s focus on evidence-based procedures and responses that will ensure the most medically appropriate and effective course of treatment for those individuals diagnosed with either maternal hemorrhages or severe hypertension/preeclampsia,” AHA wrote. “In addition, we support the proposed requirement for education of staff, and believe conducting complication-specific training and drills will better prepare providers to act effectively and efficiently when these situations arise. Further, we support the proposed provisions to provide patients and their families with the necessary educational materials to recognize symptoms that require immediate care as another important safeguard in this process.” For more on how hospitals are working to advance better health for mothers and babies, visit https://www.aha.org/better-health-for-mothers-and-babies.

Related News Articles

Headline
The AHA will host a webinar Dec. 18 at 1 p.m. ET on strategies to better protect senior leaders in hospitals. Attendees will learn ways to reduce…
Headline
A JAMA article co-authored by AHA Chief Physician Executive Chris DeRienzo, M.D., and leaders from Vizient highlights that hospitals and health systems have…
Headline
ByHeart has expanded its voluntary recall to include all Whole Nutrition Infant Formula cans and Anywhere Pack products amid an investigation by the Food and…
Headline
A study published today by Nature found that as many as 5,000 steps per day can slow cognitive decline for individuals with early signs of Alzheimer’s disease…
Headline
Rural hospital leaders recently shared strategies and insights on improving safety culture, governance and care reliability at the AHA’s Rural Patient Safety…
Headline
The Food and Drug Administration sent a warning letter to Philips last month due to quality violations found at three of its medical device facilities earlier…